MET-Targeting Anticancer Drugs-De Novo Design and Identification by Drug Repurposing
The Met protein is a cell surface receptor tyrosine kinase predominantly expressed in epithelial cells. Aberrant regulation of <i>MET</i> is manifested by numerous mechanisms including amplification, mutations, deletion, fusion of the <i>MET</i> proto-oncogene, and protein ov...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2023-07-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|